Sikkerheden ved Ribavirin- kapsler er vurderet på basis af data fra tre kliniske undersøgelser hos patienter uden tidligere eksponering for interferon (interferon- naive patienter): to undersøgelser vurderede Ribavirin i kombination med interferon alfa- 2b, en undersøgelse vurderede Ribavirin i kombination med peginterferon alfa- 2b.
The safety of Ribavirin capsules is evaluated from data from three clinical trials in patients with no previous exposure to interferon (interferon-naïve patients): two trials studied Ribavirin in combination with interferon alfa-2b, one trial studied Ribavirin in combination with peginterferon alfa-2b.